Inscripta Revenue and Competitors

Boulder, CO USA

Location

$459.5M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Inscripta's estimated annual revenue is currently $1.3M per year.(i)
  • Inscripta received $30.0M in venture funding in December 2018.
  • Inscripta's estimated revenue per employee is $77,500
  • Inscripta's total funding is $459.5M.

Employee Data

  • Inscripta has 17 Employees.(i)
  • Inscripta grew their employee count by 0% last year.

Inscripta's People

NameTitleEmail/Phone
1
Chief ScientistReveal Email/Phone
2
CEOReveal Email/Phone
3
VP Research And DevelopmentReveal Email/Phone
4
ControllerReveal Email/Phone
5
VP, Mammalian Biology and Product ManagementReveal Email/Phone
6
SVP, Synthetic Biology ProductsReveal Email/Phone
7
Chief Technology OfficerReveal Email/Phone
8
Associate Director Business DevelopmentReveal Email/Phone
9
Director, Contract Operations and Legal AffairsReveal Email/Phone
10
Director Molecular BiologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M9-10%$20MN/A
Add Company

What Is Inscripta?

Inscripta is a gene-editing technology company dedicated to creating the tools needed to revolutionize how we feed, fuel, and heal humanity.

keywords:N/A

$459.5M

Total Funding

17

Number of Employees

$1.3M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Inscripta News

2022-04-17 - CRISPR-PE Technology Market 2022 : Industry Status ...

... Horizon Discovery, Integrated DNA Technologies (IDT, Intellia Therapeutics Inc., Inscripta, Precision Bioscience, Sangoma Therapeutics,...

2022-04-17 - CRISPR-PE Technology Market 2022 : Industry Status ...

... Horizon Discovery, Integrated DNA Technologies (IDT, Intellia Therapeutics Inc., Inscripta, Precision Bioscience, Sangoma Therapeutics,...

2022-03-22 - Penn State-developed genome-editing technology licensed to ...

Inscripta intends to explore the use of Penn State's tRNA technology in its research and development activities to improve the efficiency of...

2022-03-22 - Penn State-developed genome-editing technology licensed to ...

Inscripta intends to explore the use of Penn State's tRNA technology in its research and development activities to improve the efficiency of...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.5M17-15%N/A
#2
$2M17-11%N/A
#3
$1.9M17-6%N/A
#4
N/A17N/AN/A
#5
$3.8M1721%N/A

Inscripta Funding

DateAmountRoundLead InvestorsReference
2018-03-01$55.5MCMerieux DeveloppementArticle
2018-12-20$30.0MCMultipleArticle